Found 8 matching trials
Study Assessing Safety and Therapeutic Activity of AFFITOPE® PD01A and PD03A in Patients With Early MSA PHASE1 This is a randomized controlled parallel Group phase I study to investigate...
Show More Location
University Hospital Bordeaux (Pellegrin Hospital)
Learn More & Join Trial
Safety and Immunogenicity of Repeated Doses of ABvac40 in Patients With a-MCI or Vm-AD PHASE2 Alzheimer's disease (AD) is the most common type of dementia, accounting fo...
Show More Location
Hôpital François Mitterrand
Learn More & Join Trial
Study Assessing Safety, Immunogenicity and LDLc -Lowering Activity of 2 PCSK9 Targeting AFFITOPE Vaccines in Healthy Subjects PHASE1 Study AFF012 is a single blind, single-center, randomized, placebo-controll...
Show More Location
Medical University of Vienna
Learn More & Join Trial
PRO-BOOST-LC: Whole-Gland Boost Strategies Versus SBRT Monotherapy in PSMA-Staged Localized and Locally Advanced Prostate Cancer PHASE2 PRO-BOOST-LC is a prospective, multicenter, randomized phase II/III clinica...
Show More Location
Affidea Nu-Med, Center of Oncological Diagnostics and Therapy
Learn More & Join Trial
Evaluation of a Cancer Lysate Vaccine and Montanide (Registered Trademark) ISA-51 VG With or Without the IL-15 Super-Agonist N-803 as Adjuvant Therapy for PD-L1 Negative Non-Small Cell Lung Cancer PHASE1 Background:
Surgery is the primary treatment for non-small cell lung cance...
Show More Location
National Institutes of Health Clinical Center
Learn More & Join Trial
Clinical Trial to Assess Safety and Immunogenicity of a Synthetic Vaccine Against Streptococcus Pyogenes PHASE1 This is a double-blind, randomized, placebo-controlled phase I clinical tri...
Show More Location
Multiple Locations
Learn More & Join Trial
Study Assessing Tolerability and Safety of AFFITOPE® PD03A in Patients With Early Parkinson's Disease PHASE1 Study AFF011 is a randomized controlled parallel Group phase I study to inv...
Show More Location
Medical University Innsbruck, Department of Neurology
Learn More & Join Trial
Study Assessing Tolerability and Safety and Exploring the Immunogenicity and Therapeutic Activity of AFFITOPE® PD01A in PD-GBA Patients PHASE1 This is a randomized, placebo-controlled, parallel group, patient-blind, si...
Show More Location
University Hospital Tübingen
Learn More & Join Trial